Nasdaq News

Image source: The Motley Fool.

Part of Tuesday’s selloff was because investors think the Fed is putting the coronavirus on par with past crises like the Sept. 11 terror attacks or the financial crisis. It isn’t close to carrying the economic magnitude of those events, says one strategist.

Sports apparel retailer Track & Field on Tuesday filed for an initial public offering with Brazil's securities industry regulator.

Argentina's inflation rate will be 40% in 2020, according to a central bank poll of analysts released on Tuesday, down from an estimated 41.7% in the same poll taken by the monetary authority a month earlier.

Defense contracting giant Northrop Grumman (NYSE: NOC) was awarded a $262.3 million defense contract by the U.S. Air Force this evening.

Asian shares were poised to drop on Wednesday and bonds soared, after an emergency rate cut from the U.S. Federal Reserve was unable to quell investor fears over the coronavirus's widening fallout.

The Hong Kong Monetary Authority (HKMA) lowered its base rate charged through the overnight discount window by 50 basis points to 1.5% on Wednesday, hours after the U.S. Federal Reserve delivered a rate cut of the same margin.

Activist Arussi Unda knew many across Mexico shared her fury over violence against women and impunity for the perpetrators, but she was still surprised when her vision of women staging a national one-day strike took off beyond her home state.

What happened Shares of Mastercard (NYSE: MA), American Express (NYSE: AXP), Discover Financial (NYSE: DFS), and Capital One (NYSE: COF) all fell by approximately 5% on Tuesday, following Visa's (NYSE: V) warning of a revenue shortfall due to the coronavirus outbreak. 

Wall Street stepped up preparations to deal with the impact of the coronavirus on Tuesday, testing backup plans and asking employees to work from home, as a New Yorker tested positive for the virus, bringing the prospect of the spread of the infection closer to home.

The Federal Reserve cut its benchmark interest rate by 50 basis points Tuesday morning. This was an unprecedented move to curb the fear-driven markets that we experienced last week.

Yext (YEXT) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.15. This compares to loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items.

Benefitfocus (BNFT) came out with quarterly earnings of $0.06 per share, beating the Zacks Consensus Estimate of a loss of $0.06 per share. This compares to earnings of $0.14 per share a year ago. These figures are adjusted for non-recurring items.

Cardlytics, Inc. (CDLX) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.08 per share. This compares to loss of $0.06 per share a year ago. These figures are adjusted for non-recurring items.

What happened Shares of cancer diagnostics company Exact Sciences (NASDAQ: EXAS) dropped 13.3% in January, according to the latest report from S&P Global Market Intelligence. That move erased 2019 gains and reduced the stock price to new 52-week lows.

What happened Shares of Mattel (NASDAQ: MAT) fell 19.4% in February, according to data from S&P Global Market Intelligence, on concerns that factory disruptions resulting from the coronavirus may weigh on earnings in the coming quarters.

Inovio Pharmaceuticals (NASDAQ: INO) is making progress in its efforts to develop a vaccine for SARS-CoV-2, the coronavirus that causes COVID-19. Shares of the biotech company closed up 70% on Tuesday on word that it could start a clinical trial next month.

Investment group Exor said on Tuesday it has entered a memorandum of understanding (MoU) to sell its 100% stake in Bermuda-based reinsurer PartnerRe to France's Covea for $9 billion in cash.

What happened Shares of Beyond Meat (NASDAQ: BYND) fell 18.8% in February, according to data provided by S&P Global Market Intelligence, after the maker of plant-based meat alternatives reported a loss for the fourth quarter and announced a full-year 2020 adjusted EBITDA f

The move was a further signal of the enormous disruption that the outbreak of the new coronavirus is having on the drug supply chain.